These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26189075)

  • 1. Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function.
    Guo JY; Huhtaniska S; Miettunen J; Jääskeläinen E; Kiviniemi V; Nikkinen J; Moilanen J; Haapea M; Mäki P; Jones PB; Veijola J; Isohanni M; Murray GK
    Schizophr Res; 2015 Oct; 168(1-2):297-304. PubMed ID: 26189075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.
    Ahmed M; Cannon DM; Scanlon C; Holleran L; Schmidt H; McFarland J; Langan C; McCarthy P; Barker GJ; Hallahan B; McDonald C
    Neuropsychopharmacology; 2015 Sep; 40(10):2409-17. PubMed ID: 25829144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.
    Ho BC; Andreasen NC; Ziebell S; Pierson R; Magnotta V
    Arch Gen Psychiatry; 2011 Feb; 68(2):128-37. PubMed ID: 21300943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.
    Veijola J; Guo JY; Moilanen JS; Jääskeläinen E; Miettunen J; Kyllönen M; Haapea M; Huhtaniska S; Alaräisänen A; Mäki P; Kiviniemi V; Nikkinen J; Starck T; Remes JJ; Tanskanen P; Tervonen O; Wink AM; Kehagia A; Suckling J; Kobayashi H; Barnett JH; Barnes A; Koponen HJ; Jones PB; Isohanni M; Murray GK
    PLoS One; 2014; 9(7):e101689. PubMed ID: 25036617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.
    Cahn W; Hulshoff Pol HE; Lems EB; van Haren NE; Schnack HG; van der Linden JA; Schothorst PF; van Engeland H; Kahn RS
    Arch Gen Psychiatry; 2002 Nov; 59(11):1002-10. PubMed ID: 12418933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
    Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
    Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
    Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia.
    Takahashi T; Suzuki M; Zhou SY; Tanino R; Nakamura K; Kawasaki Y; Seto H; Kurachi M
    Schizophr Res; 2010 Jun; 119(1-3):65-74. PubMed ID: 20051316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.
    Gogtay N; Sporn A; Clasen LS; Nugent TF; Greenstein D; Nicolson R; Giedd JN; Lenane M; Gochman P; Evans A; Rapoport JL
    Arch Gen Psychiatry; 2004 Jan; 61(1):17-22. PubMed ID: 14706940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive gray matter volume reduction in treatment-resistant schizophrenia.
    Anderson VM; Goldstein ME; Kydd RR; Russell BR
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.
    Andreasen NC; Liu D; Ziebell S; Vora A; Ho BC
    Am J Psychiatry; 2013 Jun; 170(6):609-15. PubMed ID: 23558429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between brain morphology and outcome in schizophrenia in a general population sample.
    Jääskeläinen E; Juola P; Kurtti J; Haapea M; Kyllönen M; Miettunen J; Tanskanen P; Murray GK; Huhtaniska S; Barnes A; Veijola J; Isohanni M
    Eur Psychiatry; 2014 Sep; 29(7):456-62. PubMed ID: 24342739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
    Fusar-Poli P; Smieskova R; Kempton MJ; Ho BC; Andreasen NC; Borgwardt S
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1680-91. PubMed ID: 23769814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic drug effects on brain morphology in first-episode psychosis.
    Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
    Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.
    Tanskanen P; Ridler K; Murray GK; Haapea M; Veijola JM; Jääskeläinen E; Miettunen J; Jones PB; Bullmore ET; Isohanni MK
    Schizophr Bull; 2010 Jul; 36(4):766-77. PubMed ID: 19015212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.